The reduction in taurine levels after α-LA was expected in view of the success of α-LA in ameliorating the changes in the hypothalamic amino acid neurotransmitters and the restoration of the control-like levels of leptin and ghrelin together with the balance between them, which confirms the anti-obesity effect of α-LA. The gene discussed is GHRL; the disease is obesity disorder.